Neuropharmacological treatment of refractory idiopathic thrombocytopenic purpura: roles of circulating catecholamines and serotonin

• References

• 1 Anisman H, Suissa A, Sklar LS. Escape deficits produced by uncontrollable stress: antagonism by dopamine and norepinephrine agonists. Behav Neural Biol 1980; 28: 34-47.
• 2 Lechin F, van der Dijs B, Orozco B. et al. Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise in severely ill patients: A model of failing to cope with stress. Psychother Psychosom 1996; 65: 129-36.
• 3 Lechin F, van der Dijs B, Lechin ME. Neuroautonomic, neuroendocrine and neuroimmune interactions. In Neurocircuitry and Neuroautonomic Disorders. Reviews and Therapeutic Strategies. Karger 2002; 57-59.
• 4 Lechin F, van der Dijs B, Lechin ME. Neuropharmacological therapy of diseases associated with uncoping stress profile (Th-2 autoimmune diseases). In. Neurocircuitry and Neuroautonomic Disorders. Reviews and Therapeutic Strategies Karger 2002; 75-82.
• 5 Gobbi G, Mirandola P, Tazzari PL. et al. Flow cytometry detection of serotonin content and release in resting and activated platelets. Br J Haematol 2003; 121: 892-6.
• 6 Dale GL, Friese P, Batar P. et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Science 2002; 415: 175-9.
• 7 Dominguez V, Govezensky T, Gevorkian G. et al. Low platelet counts do not cause bleeding in an experimental model of immune thrombocytopenic purpura in mice. Haematologica 2003; 88: 679-87.